Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18545624 | 0.83 | GAA (0.52) | GAAL3MBTL1 | |
| SCHEMBL22315405 | 0.79 | GAA (0.48) | GAAL3MBTL1KDM4E | |
| SCHEMBL7941186 | 0.75 | — | — | |
| SCHEMBL16361593 | 0.74 | GAA (0.41) | GAAL3MBTL1 | |
| SCHEMBL20850057 | 0.73 | GAA (0.47) | GAAL3MBTL1KDM4E | |
| SCHEMBL20629100 | 0.73 | GAA (0.42) | GAAL3MBTL1 | |
| SCHEMBL7941375 | 0.71 | GAA (0.40) | GAAL3MBTL1KDM4E | |
| SCHEMBL13735926 | 0.70 | GAA (0.39) | GAAL3MBTL1 | |
| SCHEMBL377190 | 0.69 | GAA (0.56) | GAAL3MBTL1KDM4E | |
| SCHEMBL18545708 | 0.69 | GAA (0.56) | GAAL3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11472790-B2 | Dinitroxide biradical compounds as polarizing agents | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2022-10-18 | — | — | US | disclosed |
| US-20200148666-A1 | DINITROXIDE BIRADICAL COMPOUNDS AS POLARIZING AGENTS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2020-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11472790-B2 | Dinitroxide biradical compounds as polarizing agents | NDC1, NUCB2, MDM4 | GAA 2894/4885L3MBTL1 1320/4885KDM4E 2856/4885 |
| US-20200148666-A1 | DINITROXIDE BIRADICAL COMPOUNDS AS POLARIZING AGENTS | NDC1, NUCB2, MDM4 | GAA 2894/4885L3MBTL1 1320/4885KDM4E 2856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.